메뉴 건너뛰기




Volumn 82, Issue 1-2, 2012, Pages 23-29

The developing clinical problem of chemotherapy-induced hepatic injury

Author keywords

Chemotherapy; Colorectal liver metastases; Sinusoidal injury; Steatohepatitis; Steatosis

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; PLATINUM COMPLEX;

EID: 84856572760     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2011.05789.x     Document Type: Review
Times cited : (14)

References (51)
  • 2
    • 2442704240 scopus 로고    scopus 로고
    • Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
    • discussion 25-7.
    • Abdalla EK, Vauthey JN, Ellis LM etal. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann. Surg. 2004; 239: 818-25; discussion 25-7.
    • (2004) Ann. Surg. , vol.239 , pp. 818-825
    • Abdalla, E.K.1    Vauthey, J.N.2    Ellis, L.M.3
  • 3
    • 0029794696 scopus 로고    scopus 로고
    • Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
    • discussion 20-2.
    • Bismuth H, Adam R, Levi F etal. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann. Surg. 1996; 224: 509-20; discussion 20-2.
    • (1996) Ann. Surg. , vol.224 , pp. 509-520
    • Bismuth, H.1    Adam, R.2    Levi, F.3
  • 4
    • 0038600610 scopus 로고    scopus 로고
    • Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases
    • Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann. Oncol. 2003; 14 (Suppl 2): ii13-6.
    • (2003) Ann. Oncol. , vol.14 , Issue.SUPPL 2
    • Adam, R.1
  • 6
    • 0041417909 scopus 로고    scopus 로고
    • Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver
    • Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br. J. Surg. 2003; 90: 963-9.
    • (2003) Br. J. Surg. , vol.90 , pp. 963-969
    • Tanaka, K.1    Adam, R.2    Shimada, H.3    Azoulay, D.4    Levi, F.5    Bismuth, H.6
  • 7
    • 9744226672 scopus 로고    scopus 로고
    • Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?
    • discussion 61-4.
    • Adam R, Pascal G, Castaing D etal. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann. Surg. 2004; 240: 1052-61; discussion 61-4.
    • (2004) Ann. Surg. , vol.240 , pp. 1052-1061
    • Adam, R.1    Pascal, G.2    Castaing, D.3
  • 8
    • 33644822617 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note
    • Bilchik AJ, Poston G, Curley SA etal. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J. Clin. Oncol. 2005; 23: 9073-8.
    • (2005) J. Clin. Oncol. , vol.23 , pp. 9073-9078
    • Bilchik, A.J.1    Poston, G.2    Curley, S.A.3
  • 9
    • 42249100008 scopus 로고    scopus 로고
    • Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases
    • Covey AM, Brown KT, Jarnagin WR etal. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann. Surg. 2008; 247: 451-5.
    • (2008) Ann. Surg. , vol.247 , pp. 451-455
    • Covey, A.M.1    Brown, K.T.2    Jarnagin, W.R.3
  • 10
    • 40749107362 scopus 로고    scopus 로고
    • Perioperative chemotherapy for resectable hepatic metastases
    • Kopetz S, Vauthey JN. Perioperative chemotherapy for resectable hepatic metastases. Lancet 2008; 371: 963-5.
    • (2008) Lancet , vol.371 , pp. 963-965
    • Kopetz, S.1    Vauthey, J.N.2
  • 11
    • 34347234594 scopus 로고    scopus 로고
    • Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome
    • Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J. Gastrointest. Surg. 2007; 11: 860-8.
    • (2007) J. Gastrointest. Surg. , vol.11 , pp. 860-868
    • Pawlik, T.M.1    Olino, K.2    Gleisner, A.L.3    Torbenson, M.4    Schulick, R.5    Choti, M.A.6
  • 12
    • 33846309211 scopus 로고    scopus 로고
    • Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes
    • Sahajpal A, Vollmer CM, Jr, Dixon E etal. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J. Surg. Oncol. 2007; 95: 22-7.
    • (2007) J. Surg. Oncol. , vol.95 , pp. 22-27
    • Sahajpal, A.1    Vollmer Jr, C.M.2    Dixon, E.3
  • 13
    • 33747077466 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases
    • Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br. J. Surg. 2006; 93: 1001-6.
    • (2006) Br. J. Surg. , vol.93 , pp. 1001-1006
    • Capussotti, L.1    Muratore, A.2    Mulas, M.M.3    Massucco, P.4    Aglietta, M.5
  • 14
    • 19744365905 scopus 로고    scopus 로고
    • Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
    • Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J. Am. Coll. Surg. 2005; 200: 845-53.
    • (2005) J. Am. Coll. Surg. , vol.200 , pp. 845-853
    • Fernandez, F.G.1    Ritter, J.2    Goodwin, J.W.3    Linehan, D.C.4    Hawkins, W.G.5    Strasberg, S.M.6
  • 15
    • 33750961459 scopus 로고    scopus 로고
    • Benefits and risks of neoadjuvant therapy for liver metastases
    • Nordlinger B, Benoist S. Benefits and risks of neoadjuvant therapy for liver metastases. J. Clin. Oncol. 2006; 24: 4954-5.
    • (2006) J. Clin. Oncol. , vol.24 , pp. 4954-4955
    • Nordlinger, B.1    Benoist, S.2
  • 16
    • 42949130734 scopus 로고    scopus 로고
    • Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer
    • Gruenberger B, Tamandl D, Schueller J etal. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J. Clin. Oncol. 2008; 26: 1830-5.
    • (2008) J. Clin. Oncol. , vol.26 , pp. 1830-1835
    • Gruenberger, B.1    Tamandl, D.2    Schueller, J.3
  • 17
    • 44849083292 scopus 로고    scopus 로고
    • Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases
    • White RR, Schwartz LH, Munoz JA etal. Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases. J. Surg. Oncol. 2008; 97: 601-4.
    • (2008) J. Surg. Oncol. , vol.97 , pp. 601-604
    • White, R.R.1    Schwartz, L.H.2    Munoz, J.A.3
  • 18
    • 33846641607 scopus 로고    scopus 로고
    • Preoperative chemotherapy and the outcome of liver resection for colorectal metastases
    • discussion 65-6.
    • Hewes JC, Dighe S, Morris RW, Hutchins RR, Bhattacharya S, Davidson BR. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J. Surg. 2007; 31: 353-64; discussion 65-6.
    • (2007) World J. Surg. , vol.31 , pp. 353-364
    • Hewes, J.C.1    Dighe, S.2    Morris, R.W.3    Hutchins, R.R.4    Bhattacharya, S.5    Davidson, B.R.6
  • 19
    • 62849128239 scopus 로고    scopus 로고
    • Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases
    • Chun YS, Laurent A, Maru D, Vauthey JN. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol. 2009; 10: 278-86.
    • (2009) Lancet Oncol. , vol.10 , pp. 278-286
    • Chun, Y.S.1    Laurent, A.2    Maru, D.3    Vauthey, J.N.4
  • 20
    • 30144435398 scopus 로고    scopus 로고
    • Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
    • Karoui M, Penna C, Amin-Hashem M etal. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann. Surg. 2006; 243: 1-7.
    • (2006) Ann. Surg. , vol.243 , pp. 1-7
    • Karoui, M.1    Penna, C.2    Amin-Hashem, M.3
  • 21
    • 33750957147 scopus 로고    scopus 로고
    • Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
    • Aloia T, Sebagh M, Plasse M etal. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J. Clin. Oncol. 2006; 24: 4983-90.
    • (2006) J. Clin. Oncol. , vol.24 , pp. 4983-4990
    • Aloia, T.1    Sebagh, M.2    Plasse, M.3
  • 22
    • 0037267766 scopus 로고    scopus 로고
    • Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases
    • discussion 16-7.
    • Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J. Gastrointest. Surg. 2003; 7: 109-15; discussion 16-7.
    • (2003) J. Gastrointest. Surg. , vol.7 , pp. 109-115
    • Allen, P.J.1    Kemeny, N.2    Jarnagin, W.3    DeMatteo, R.4    Blumgart, L.5    Fong, Y.6
  • 24
    • 0024397765 scopus 로고
    • Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure
    • Didolkar MS, Fitzpatrick JL, Elias EG etal. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg. Gynecol. Obstet. 1989; 169: 17-26.
    • (1989) Surg. Gynecol. Obstet. , vol.169 , pp. 17-26
    • Didolkar, M.S.1    Fitzpatrick, J.L.2    Elias, E.G.3
  • 25
    • 3843062418 scopus 로고    scopus 로고
    • Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy
    • Carlo WF, Hummer AJ, Schwartz L etal. Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy. J. Surg. Oncol. 2004; 87: 85-90.
    • (2004) J. Surg. Oncol. , vol.87 , pp. 85-90
    • Carlo, W.F.1    Hummer, A.J.2    Schwartz, L.3
  • 26
    • 63649164527 scopus 로고    scopus 로고
    • Liver failure after major hepatic resection
    • doi:10.1007/s00534-008-0017-y.
    • Garcea G, Maddern GJ. Liver failure after major hepatic resection. J. Hepatobiliary Pancreat Surg. 2008; doi:10.1007/s00534-008-0017-y.
    • (2008) J. Hepatobiliary Pancreat Surg.
    • Garcea, G.1    Maddern, G.J.2
  • 27
    • 40749149728 scopus 로고    scopus 로고
    • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
    • Nordlinger B, Sorbye H, Glimelius B etal. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-16.
    • (2008) Lancet , vol.371 , pp. 1007-1016
    • Nordlinger, B.1    Sorbye, H.2    Glimelius, B.3
  • 28
    • 34249328503 scopus 로고    scopus 로고
    • Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study
    • McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann. Surg. 2007; 245: 923-30.
    • (2007) Ann. Surg. , vol.245 , pp. 923-930
    • McCormack, L.1    Petrowsky, H.2    Jochum, W.3    Furrer, K.4    Clavien, P.A.5
  • 31
    • 36348974014 scopus 로고    scopus 로고
    • Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis
    • Gomez D, Malik HZ, Bonney GK etal. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br. J. Surg. 2007; 94: 1395-402.
    • (2007) Br. J. Surg. , vol.94 , pp. 1395-1402
    • Gomez, D.1    Malik, H.Z.2    Bonney, G.K.3
  • 32
    • 10744231437 scopus 로고    scopus 로고
    • Impact of steatosis on perioperative outcome following hepatic resection
    • Kooby DA, Fong Y, Suriawinata A etal. Impact of steatosis on perioperative outcome following hepatic resection. J. Gastrointest. Surg. 2003; 7: 1034-44.
    • (2003) J. Gastrointest. Surg. , vol.7 , pp. 1034-1044
    • Kooby, D.A.1    Fong, Y.2    Suriawinata, A.3
  • 34
    • 4644320061 scopus 로고    scopus 로고
    • Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival
    • discussion 57-8.
    • Adam R, Delvart V, Pascal G etal. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg. 2004; 240: 644-57; discussion 57-8.
    • (2004) Ann. Surg. , vol.240 , pp. 644-657
    • Adam, R.1    Delvart, V.2    Pascal, G.3
  • 35
    • 51749125769 scopus 로고    scopus 로고
    • Effect of preoperative chemotherapy on liver resection for colorectal liver metastases
    • Mehta NN, Ravikumar R, Coldham CA etal. Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur. J. Surg. Oncol. 2008; 34: 782-6.
    • (2008) Eur. J. Surg. Oncol. , vol.34 , pp. 782-786
    • Mehta, N.N.1    Ravikumar, R.2    Coldham, C.A.3
  • 36
    • 43449126960 scopus 로고    scopus 로고
    • Pathological analysis of hepatic injury after oxaliplatin-based neoadjuvant chemotherapy of colorectal cancer liver metastases: results of the EORTC Intergroup phase III study 40983
    • abstr 241
    • Julie C, Lutz M, Aust D etal. Pathological analysis of hepatic injury after oxaliplatin-based neoadjuvant chemotherapy of colorectal cancer liver metastases: results of the EORTC Intergroup phase III study 40983. J. Clin. Oncol. 2007; 25: (abstr 241).
    • (2007) J. Clin. Oncol. , vol.25
    • Julie, C.1    Lutz, M.2    Aust, D.3
  • 37
    • 78751667108 scopus 로고    scopus 로고
    • Liver resection in obese patients: results of a case-control study
    • Vigano L, Kluger MD, Laurent A etal. Liver resection in obese patients: results of a case-control study. HPB (Oxford) 2011; 13: 103-11.
    • (2011) HPB (Oxford) , vol.13 , pp. 103-111
    • Vigano, L.1    Kluger, M.D.2    Laurent, A.3
  • 38
    • 0033922244 scopus 로고    scopus 로고
    • Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection
    • Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J. Am. Coll. Surg. 2000; 191: 38-46.
    • (2000) J. Am. Coll. Surg. , vol.191 , pp. 38-46
    • Belghiti, J.1    Hiramatsu, K.2    Benoist, S.3    Massault, P.4    Sauvanet, A.5    Farges, O.6
  • 39
    • 0026751233 scopus 로고
    • Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies
    • Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992; 53: 957-78.
    • (1992) Transplantation , vol.53 , pp. 957-978
    • Clavien, P.A.1    Harvey, P.R.2    Strasberg, S.M.3
  • 40
    • 43449090668 scopus 로고    scopus 로고
    • Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases
    • Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur. J. Surg. Oncol. 2008; 34: 609-14.
    • (2008) Eur. J. Surg. Oncol. , vol.34 , pp. 609-614
    • Morris-Stiff, G.1    Tan, Y.M.2    Vauthey, J.N.3
  • 41
    • 0034655695 scopus 로고    scopus 로고
    • Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation
    • Marcos A, Fisher RA, Ham JM etal. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000; 69: 1375-9.
    • (2000) Transplantation , vol.69 , pp. 1375-1379
    • Marcos, A.1    Fisher, R.A.2    Ham, J.M.3
  • 42
    • 63649142566 scopus 로고    scopus 로고
    • Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases
    • doi:10.1007/s00534-008-0016-z.
    • Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J. Hepatobiliary Pancreat Surg. 2008; doi:10.1007/s00534-008-0016-z.
    • (2008) J. Hepatobiliary Pancreat Surg.
    • Khan, A.Z.1    Morris-Stiff, G.2    Makuuchi, M.3
  • 43
    • 33646021275 scopus 로고    scopus 로고
    • Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired
    • Cho JY, Suh KS, Kwon CH, Yi NJ, Lee KU. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 2006; 139: 508-15.
    • (2006) Surgery , vol.139 , pp. 508-515
    • Cho, J.Y.1    Suh, K.S.2    Kwon, C.H.3    Yi, N.J.4    Lee, K.U.5
  • 44
    • 0036729447 scopus 로고    scopus 로고
    • The utility of radiological imaging in nonalcoholic fatty liver disease
    • Saadeh S, Younossi ZM, Remer EM etal. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.
    • (2002) Gastroenterology , vol.123 , pp. 745-750
    • Saadeh, S.1    Younossi, Z.M.2    Remer, E.M.3
  • 45
    • 33646457231 scopus 로고    scopus 로고
    • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
    • Vauthey JN, Pawlik TM, Ribero D etal. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol. 2006; 24: 2065-72.
    • (2006) J. Clin. Oncol. , vol.24 , pp. 2065-2072
    • Vauthey, J.N.1    Pawlik, T.M.2    Ribero, D.3
  • 47
    • 28044446543 scopus 로고    scopus 로고
    • The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
    • Hamaguchi M, Kojima T, Takeda N etal. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005; 143: 722-8.
    • (2005) Ann. Intern. Med. , vol.143 , pp. 722-728
    • Hamaguchi, M.1    Kojima, T.2    Takeda, N.3
  • 48
    • 37549068554 scopus 로고    scopus 로고
    • Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy
    • Nakano H, Oussoultzoglou E, Rosso E etal. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann. Surg. 2008; 247: 118-24.
    • (2008) Ann. Surg. , vol.247 , pp. 118-124
    • Nakano, H.1    Oussoultzoglou, E.2    Rosso, E.3
  • 49
    • 11144354740 scopus 로고    scopus 로고
    • Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
    • Rubbia-Brandt L, Audard V, Sartoretti P etal. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol. 2004; 15: 460-6.
    • (2004) Ann. Oncol. , vol.15 , pp. 460-466
    • Rubbia-Brandt, L.1    Audard, V.2    Sartoretti, P.3
  • 50
    • 0036125693 scopus 로고    scopus 로고
    • Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)
    • DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 2002; 22: 27-42.
    • (2002) Semin. Liver Dis. , vol.22 , pp. 27-42
    • DeLeve, L.D.1    Shulman, H.M.2    McDonald, G.B.3
  • 51
    • 0037775811 scopus 로고    scopus 로고
    • Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases
    • discussion 9-70.
    • Kooby DA, Stockman J, Ben-Porat L etal. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann. Surg. 2003; 237: 860-9; discussion 9-70.
    • (2003) Ann. Surg. , vol.237 , pp. 860-869
    • Kooby, D.A.1    Stockman, J.2    Ben-Porat, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.